AAV8-GUCY2D gene therapy (Fondazione Telethon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV8-GUCY2D gene therapy (Fondazione Telethon)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionRetinal guanylyl cyclase 1 gene transference
TargetsRetinal guanylyl cyclase 1
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFondazione Telethon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFondazione Telethon
Active IndicationsN/A
Inactive IndicationsLeber Congenital Amaurosis

Other Information

ATC CodeN/A
Related LinksN/A